연구동향 분석

폐경 전 유방암 환자의 치료 전·후 골밀도 변화 분석

김수진(Su Jin Kim) 손순룡(Soon Yong Son) 최관우(Kwan-Woo Choi) 이주아(Joo Ah Lee) 민정환(Jung-Whan Min) 김현수(Hyun-Soo Kim) 마상철(Sang-Chull Ma) 이종석(Jong-Seok Lee) 유병규(Beong-Gyu Yoo) 2014년

논문상세정보
인용/피인용
' 폐경 전 유방암 환자의 치료 전·후 골밀도 변화 분석' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • bmd(bonemineraldensity)
  • breast cancer
  • high-riskgroup
  • 고위험군
  • 골밀도
  • 유방암
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,596 0

0.0%

' 폐경 전 유방암 환자의 치료 전·후 골밀도 변화 분석' 의 참고문헌

  • 폐경전 성인직장여성의 골밀도와 생리적 특성 및 생활습관과의 관련성
    임화재 한국식품영양과학회지 33 (2) : 339 ~ 348 [2004]
  • What Breast Cancer Survivors Need to Know About Osteoporosis
    Bethesda National Institutes of Health 2 : 8 ~ 18 [2012]
  • Toxicity of aromatase inhibitors
    Pandya N Semin Oncol 33 (6) : 688 ~ 695 [2006]
  • The effect of X-rays on bone
    Williams HJ Eur Radiol 16 : 619 ~ 633 [2006]
  • Testing an intervention for preventing osteoporosis in postmenopausal breast cancer survivors.
    Waltman NL J Nurs Scholarsh 35 (4) : 333 ~ 338 [2003]
  • Tamoxifen treatment after adjuvunt chemotherapy pausal patients depending on menstrual status
    Vehmanen L Journal of Clinical Oncolohy 24 : 675 ~ [2006]
  • Rotterdam Study, Bone mineral density and the risk of breast cancer:the Rotterdam Study
    van der Klift M Bone 32 : 211 ~ 216 [2003]
  • Practical guidance for the management of aromatase inhibitor-associated bone loss
    Hadji P1 Ann Oncol 19 : 1407 ~ 1416 [2008]
  • Physician’guide for diagnosis and treatment of osteoporosis
  • Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer
    Shapiro CL J Clin Oncol 19 : 3306 ~ 3311 [2001]
  • NCCN task force report: bone health in cancer care
    Gralow JR J Natl ComprCanc Netw 3 : 31 ~ 32 [2009]
  • Low bone density in breastcancer survivors in Korea: prevalence, risk factors and associations withhealth-related quality of life
    Kim SH Eur J Oncol Nurs 17 : 196 ~ 203 [2013]
  • Lifestyle determinants of bone mineral : A comparison between prepubertal Asian-and Caucasian-Canadian boys and girls
    Mckay HA Calcified Tissue International 66 : 320 ~ 324 [2000]
  • Fracture risk among breast cancer survivors: results from the women’health initiative observational study
    Chen Z Arch Intern Med 165 : 552 ~ 558 [2005]
  • Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer
    Lønning PE J Clin Oncol 23 : 5126 ~ 5137 [2005]
  • Cecil text- book of medicine
    Finkelstein JS W.B. Saunders : 1366 ~ 1373 [2000]
  • Cancer-treatment-induced bone loss, part 1
    Michaud LB Am J Health Syst Pharm 63 : 419 ~ 430 [2006]
  • Cancer Facts and Figures
    National Cancer Information Center
  • Breast cancer fact sheet
    Korean Breast Cancer Society [2006]
  • Bone-mass peak in multiparity and reduced risk of bone-fractures in menopause
    Cure-Cure C International Journal of Gynaecology and Obstetrics 76 : 285 ~ 291 [2002]
  • Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer
    Bruning PF Br J Cancer 61 : 308 ~ 310 [1990]
  • Bone fragility induced by X-ray irradiation in relation to cortical bone mineral content
    Nyaruba MM Acta Radiol 39 : 43 ~ 46 [1998]
  • American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer
    Hillner BE J Clin Oncol 21 : 4042 ~ 4057 [2003]
  • A high ncidence of vertebral fracture in women with breast cancer
    Kanis JA Br J Cancer 79 : 1179 ~ 1180 [1999]
  • A high incidence of vertebral fracture in women with breast cancer
    Kanis JA Br J Cancer 79 : 1178 ~ [1999]